Ixazomib
- Introduction
- Newest Products
Introduction
Ixazomib
Ixazomib citrate is a proteasome inhibitor that acts by preventing cell growth in solid tumours. It is an anti-cancer agent that is used for treatment of multiple myeloma. Compared with bortezomib, Ixazomib citrate obtains higher pharmacokinetics, efficacy, and anticancer activity.
Newest Products
| Image | Part # | Description | manufacturer | Stock | RFQ | |
|---|---|---|---|---|---|---|
|
|
(αR)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetate (179324-87-9) |
CAS: 179324-87-9; Ixazomib manufacturer; Ixazomib intermediate; Anti-Tumor
|
|
In Stock
|
|
|
|
|
Ixazomib Citrate (1201902-80-8) |
CAS: 1201902-80-8; Ixazomib manufacturer; Ixazomib API; Ixazomib proteasome inhibitor; Anti-Tumor
|
|
In Stock
|
|
|
|
|
2-(2,5-dichlorobenzamido)acetic acid (667403-46-5) |
CAS: 667403-46-5; Ixazomib manufacturer; Ixazomib intermediate; Anti-Tumor
|
|
In Stock
|
|
